Skip to main content
Premium Trial:

Request an Annual Quote

Metamark Signs Coverage Deal With Anthem BCBS of Georgia

NEW YORK (GenomeWeb) – Cancer diagnostics firm Metamark Genetics has announced a coverage agreement with Anthem Blue Cross Blue Shield of Georgia.

Under the terms of the agreement, BCBS of Georgia will provide its members with in-network access to Metamark's suite of tests for urologic cancer.

Financial and other terms of the agreement were not disclosed.

"There is a growing recognition among payers nationwide of the benefits from our distinctive approach," Metamark CEO Jerry Williamson said in a statement.

The Georgia BCBS deal is the latest coverage and reimbursement victory for Cambridge, Massachusetts-based Metamark. Last month, Metamark announced that three Medicare contractors have issued draft local coverage determinations proposing reimbursement for the firm's proteomic ProMark prognostic test for early-stage prostate cancer.

The firm also has a coverage deal with Highmark Blue Shield. As of January, Metamark is the sole seller of the Hologic Progensa PCA3 prostate cancer test.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.